By Business/Source
Currency:AUD
2025/FY
Stock NameRevenueRatio
Device development for new medical treatments1.17M100.00%
By Country/Region
Currency:AUD
2025/FY
Stock NameRevenueRatio
Europe869.56K74.27%
Middle East286.23K24.45%
APAC (Australia + New Zealand)15K1.28%
